News
-
-
-
-
-
-
-
-
PRESS RELEASE
THX Pharma announces the launch of a capital increase with preferential subscription rights of nearly EUR 8 million
THX Pharma launches a €8 million capital increase to fund rare neurological drug development, with 75.5% commitments secured. Batten-1 and TX01 to lead clinical and commercial endeavors with strategic shift to international markets. Investment opportunities for various tax schemes -
-
PRESS RELEASE
Air France-KLM finalise l’acquisition d’une participation de 2,3% dans le capital de la compagnie aérienne WestJet
Air France-KLM finalise l’acquisition d’une participation de 2,3% dans le capital de la compagnie aérienne WestJet. Une transaction stratégique renforçant les liens entre les partenaires